Support 100 years of independent journalism.

  1. Science & Tech
31 March 2021updated 29 Jun 2021 1:23pm

The fight over Palantir’s role in the NHS is heating up

Digital rights campaigners have called on the government to provide proof that it hasn’t made concessions in the legal battle.

By Oscar Williams

NHS England has been embroiled in a war of words over its work with Peter Thiel’s controversial data engineering firm Palantir after digital rights campaigners claimed their latest legal victory.

On Tuesday 30 March campaigners at Foxglove and OpenDemocracy revealed the government had agreed to host a series of “citizen juries” before deciding if a tool – developed by Palantir and other tech firms to predict NHS demand during the pandemic – would be repurposed for non-Covid uses. The campaigners have warned that there has been a lack of accountability surrounding Palantir’s work processing sensitive health data, noting that its contracts, worth up to £24.5m, were awarded without competitive tender.

Hours later, NHS England’s press office issued a terse rebuttal. “Actually OpenDemocracy have had to drop their court case unilaterally as it was apparent even to them that the NHS has always acted in accordance with its legal responsibilities,” a spokesperson said. “They therefore stood no chance of succeeding in their completely spurious claim. It would be more honest if they actually came clean with their crowdfunders that far from ‘winning’ this case they had no choice but to drop it when they realised they hadn’t a leg to stand on.”

Sources close to the deal told the New Statesman that the citizen juries had been arranged before the legal action was taken. Foxglove accepts that NHS England had agreed to consult the public on the future use of patient data, but is adamant that it had not previously conceded that the use of the datastore for non-pandemic purposes would depend on the outcome of citizen juries.

“In the last 12 months OpenDemocracy asked the government time and time again to consult the public about the datastore,” Martha Dark, a director at Foxglove, told the New Statesman this morning. “Their response was continuously that they were not required to. If they had planned to engage the public about the future of the datastore and Palantir’s role in it before being sued, they had literally months​ of legal correspondence in which to tell us that was their plan. They didn’t.”

Select and enter your email address Quick and essential guide to domestic and global politics from the New Statesman's politics team. A weekly newsletter helping you fit together the pieces of the global economic slowdown. The New Statesman’s global affairs newsletter, every Monday and Friday. The best of the New Statesman, delivered to your inbox every weekday morning. The New Statesman’s weekly environment email on the politics, business and culture of the climate and nature crises - in your inbox every Thursday. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A newsletter showcasing the finest writing from the ideas section and the NS archive, covering political ideas, philosophy, criticism and intellectual history - sent every Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.
  • Administration / Office
  • Arts and Culture
  • Board Member
  • Business / Corporate Services
  • Client / Customer Services
  • Communications
  • Construction, Works, Engineering
  • Education, Curriculum and Teaching
  • Environment, Conservation and NRM
  • Facility / Grounds Management and Maintenance
  • Finance Management
  • Health - Medical and Nursing Management
  • HR, Training and Organisational Development
  • Information and Communications Technology
  • Information Services, Statistics, Records, Archives
  • Infrastructure Management - Transport, Utilities
  • Legal Officers and Practitioners
  • Librarians and Library Management
  • Management
  • Marketing
  • OH&S, Risk Management
  • Operations Management
  • Planning, Policy, Strategy
  • Printing, Design, Publishing, Web
  • Projects, Programs and Advisors
  • Property, Assets and Fleet Management
  • Public Relations and Media
  • Purchasing and Procurement
  • Quality Management
  • Science and Technical Research and Development
  • Security and Law Enforcement
  • Service Delivery
  • Sport and Recreation
  • Travel, Accommodation, Tourism
  • Wellbeing, Community / Social Services
I consent to New Statesman Media Group collecting my details provided via this form in accordance with the Privacy Policy

Dark added: “Make no mistake, the government have now agreed to consult the public because of this case. This is just the start of the democratic debate we need about Palantir’s role in the NHS – a few patient juries aren’t enough – but they had refused to give an inch about the public’s proper role until we sued them, so this is an important principle conceded. And we invite them to publish their legal correspondence with us in full so the public can see their formal position before they were sued, versus after.”

Content from our partners
The cost-of-living crisis is hitting small businesses – Liz Truss must act
How industry is key for net zero
How to ensure net zero brings good growth and green jobs

[See also: How one of America’s most controversial billionaires cracked the NHS]

NHS England did not immediately respond to a request for comment on whether it would publish the legal correspondence. The New Statesman asked on Tuesday afternoon for evidence that the citizen juries it had previously agreed to host would focus on the use of the Covid-19 datastore.

As the New Statesman has previously reported, many in Whitehall believe the datastore has improved the NHS’s response to the pandemic.

But Foxglove and OpenDemocracy have raised concerns about Palantir’s presence in the health service, including whether it could harm trust among minority ethnic communities given its work at the US border. Palantir directed the New Statesman‘s queries to NHS England.